Orchard Therapeutics (ORTX) PT Lowered to $4 at Stifel
Tweet
Share
E-mailGet Alerts ORTX Hot Sheet
Price: $16.70 --0%
Rating Summary:
6 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Rating Summary:
6 Buy, 3 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 9
Join SI Premium – FREE
Stifel analyst Dae Gon Ha lowered the price target on Orchard Therapeutics (NASDAQ: ORTX) to $4.00 (from $5.00) while maintaining a Buy rating.
You May Also Be Interested In
- SanDisk (SNDK) PT Raised to $1,600 at RBC Capital
- Porsche AG (P911:GR) PT Lowered to EUR45 at RBC Capital
- Fate Therapeutics (FATE) PT Raised to $3.50 at Wells Fargo
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
